Answer the question
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Now I have comprehensive information from authoritative textbooks. Let me compile the full answer.
Pulmonology Case Study 21 — Complete Analysis
Patient: Female, 52 years old
Key findings: Post-flu onset of fever (39.8°C), left-sided chest pain, hemoptysis, dry cough, general weakness → acute deterioration on day 5; left lower lobe infiltration with two cavities containing effusion on CXR; dull percussion + weakened vesicular breathing + fine-bubbled rales + bronchial breathing on the left below the scapular angle; tachycardia 110 bpm; BP 90/60 mmHg; RR 32/min.
1. Leading Syndromes (with Explanation of Symptoms)
A. Syndrome of Pulmonary Cavitation (Lung Destruction/Abscess)
The hallmark of this case. Justified by:
- CXR: Two cavities containing air-fluid levels against background of lower lobe infiltration — classic abscess appearance
- Bronchial breathing over the left lower lobe (sound conducted through patent bronchus communicating with cavity)
- Fine-bubbled (crepitant) rales — fluid movement at cavity walls
- Hemoptysis — erosion of vessels adjacent to necrotic tissue
- Fever (39.8°C), severe toxicity, rapid deterioration — suppurative process
B. Syndrome of Pulmonary Infiltration (Inflammatory Consolidation)
- Dull percussion below left scapular angle — consolidated/fluid-filled lung tissue
- Weakened vesicular breathing — reduced air entry to infiltrated areas
- Sonorous moist rales — secretions in larger airways
- Radiographic "focal and large drainage shadows" (perilesional infiltrate surrounding cavities)
- Severe leukocytosis expected (not yet stated but implied by toxic presentation)
C. Syndrome of Respiratory Failure (Acute)
- RR 32/min (tachypnea — normal ≤20)
- Forced orthopneic position — cannot breathe lying flat
- Acrocyanosis — peripheral O₂ desaturation
- Shallow breathing — pain-limited excursion
- Left chest lagging in the act of breathing — ipsilateral splinting due to pleurisy/pain
D. Syndrome of Systemic Inflammatory Response / Sepsis
- Fever 39.8°C, chills, sweating — systemic infection
- BP 90/60 mmHg — hypotension consistent with early septic shock
- HR 110 bpm (ECG: sinus tachycardia) — compensatory response
- Moist, moderately pale skin — peripheral vasodilation + anemia from chronic/acute infection
- Severe general weakness, lack of appetite
E. Pleuritic Syndrome
- Sharp left-sided chest pain aggravated by deep breathing — parietal pleural irritation
- Accentuated by the finding of perifocal pleural reaction on CXR (effusion against the background of infiltration)
2. Differential Diagnosis of the Leading Syndrome (Pulmonary Cavitation)
The leading syndrome is lung cavitation with abscess formation. The differential:
| Condition | For | Against |
|---|---|---|
| Lung Abscess (Primary) ✓ | Post-influenzal onset, fever, hemoptysis, 2 cavities with fluid levels, lower lobe, acute course, pain, severe toxicity | — |
| Cavitary Tuberculosis | Cavitation, hemoptysis, fever, sweating, weight loss | Acute 5-day course is atypical (TB is subacute/chronic); usually upper lobes; no mention of TB contacts; no night sweats for weeks |
| Cavitary Lung Cancer | Older patient, hemoptysis, weight loss, cavitation | Acute febrile onset is atypical; rapid deterioration in 5 days unusual; bilateral cavities more typical of metastatic disease |
| Pulmonary Gangrene (Necrotizing Pneumonia) | Severe acute course, multiple cavities, high fever, toxemia, fluid levels | Usually even more rapidly destructive; often produces putrid sputum; can coexist with abscess |
| Empyema with Bronchopleural Fistula | Fluid level on CXR, pleural signs, fever | Air-fluid level in pleural space vs. within lung parenchyma; CT distinguishes; bronchial breathing pattern favors intraparenchymal cavity |
| Cavitary Echinococcosis | Cavitary lesion, hemoptysis | Typically slow-growing, no acute febrile onset, geographic/exposure history needed |
Conclusion: The acute post-influenzal onset, left lower lobe location, two cavities with fluid levels on background infiltration, pronounced systemic toxicity, and hemoptysis are most consistent with acute lung abscess, likely secondary to post-influenzal necrotizing pneumonia (influenza predisposes via mucociliary destruction and aspiration).
3. Preliminary Diagnosis (with Justification)
Acute bilateral post-influenzal abscess of the lower lobe of the left lung, complicated by pleural reaction (parapneumonic effusion). Respiratory failure grade II. Sepsis/systemic inflammatory response syndrome.
Justification:
- "Post-influenzal": Patient explicitly ill after influenza; influenza causes epithelial necrosis and predisposes to secondary bacterial pneumonia with abscess (classically S. aureus, also anaerobes, Klebsiella, S. pneumoniae)
- "Abscess": Two CXR cavities with air-fluid levels in a background of infiltration is pathognomonic; clinical signs match (bronchial breath sounds, rales, hemoptysis)
- "Lower lobe of left lung": Dull percussion, signs below scapular angle; CXR drainage shadows in lower lobe
- "Pleural reaction": "Effusion visible against background of infiltration" — perifocal exudative pleuritis or early empyema
- Respiratory failure: RR 32, acrocyanosis, forced position
- Sepsis: BP 90/60, HR 110, fever 39.8°C, severe toxicity — meets SIRS criteria with known infection source
— Harrison's Principles of Internal Medicine 22E, Lung Abscess chapter; Fishman's Pulmonary Diseases, Chapter 127
4. Examination Plan with Expected Results
Laboratory
| Test | Expected Result |
|---|---|
| CBC with differential | Leukocytosis >15–20×10⁹/L, left shift (band neutrophilia >10%), elevated ESR >50 mm/h; possible anemia (Hb ↓) |
| CRP, procalcitonin | Markedly elevated (CRP >100 mg/L, PCT >2 ng/mL) — supports bacterial sepsis |
| Blood cultures (×2, aerobic + anaerobic) | May isolate causative organism (S. aureus, Klebsiella, anaerobes, Streptococcus) |
| Sputum Gram stain + culture + sensitivity | Polymicrobial or single pathogen; guides antibiotic choice |
| Sputum for AFB smear and culture | Expected negative (to exclude TB) |
| Sputum cytology | To exclude malignant cells |
| Biochemical panel (BMP) | Possible ↑ urea, creatinine (pre-renal from sepsis); ↓ albumin; ↑ LDH; ↑ AST/ALT (systemic inflammation) |
| Coagulation (INR, D-dimer) | May be elevated — sepsis-associated coagulopathy |
| ABG (arterial blood gas) | Hypoxemia (PaO₂ <60 mmHg), possible hypocapnia (hyperventilation) or hypercapnia if severe |
| Urinalysis | Protein/casts possible (toxic nephropathy) |
| Influenza PCR/rapid test | Confirm preceding influenza A/B |
Instrumental
| Test | Expected Result |
|---|---|
| Chest X-ray (PA + lateral) | Two left lower lobe cavities with air-fluid levels; perilesional infiltration; possible pleural effusion; drain shadows |
| Chest CT with contrast | Gold standard: defines cavity walls, internal structure (necrotic debris vs. fluid), rules out obstructing tumor, assesses extent of infiltration, confirms or rules out empyema vs. lung abscess |
| Bronchoscopy | May show purulent secretion draining from bronchus; allows BAL, protected brush specimen culture, biopsy if tumor suspected |
| Echocardiography | Assess cardiac function if septic shock; rule out endocarditis (rare but possible source) |
| ECG | Already done: sinus tachycardia; serial monitoring for arrhythmia |
| Pulse oximetry / SpO₂ | Expected ≤90% on room air |
| Pleural ultrasound | Characterize pleural effusion; guide thoracentesis if indicated |
| Thoracentesis (if significant effusion) | Exudate (Light's criteria); culture; pH <7.2 → empyema requiring drainage |
5. Treatment Plan
Regime
- Immediate hospitalization in pulmonology or ICU (given septic hemodynamics: BP 90/60, HR 110, RR 32)
- Bed rest, semi-Fowler's or position on the affected (left) side to promote drainage via postural drainage
- Postural drainage + percussion physiotherapy (chest PT) 2–3× daily
- Continuous SpO₂ monitoring, IV access, fluid balance chart
Diet
- High-calorie, high-protein diet (2000–2500 kcal/day) — prevent catabolism; protein 1.5 g/kg/day
- Small, frequent meals
- Adequate hydration (oral + IV) — correct hypotension
Medication
1. Antibiotics (Primary Treatment)
The preferred regimen for post-influenzal lung abscess covers anaerobes, S. aureus, Gram-negatives:
Option A — First line (clindamycin-based):
- Clindamycin 600 mg IV q8h (three times daily) — superior to penicillin alone for anaerobes producing β-lactamases; until clinical improvement (fever resolves), then 300 mg PO q6h (four times daily)
- Continue until CXR/CT shows abscess resolution or small scar residuum — typically 6–8 weeks total
Option B — β-Lactam/β-Lactamase inhibitor combination:
- Ampicillin-sulbactam 3 g IV q6h, then transition to amoxicillin-clavulanate 875/125 mg PO q12h once stable
- Alternative: Piperacillin-tazobactam 4.5 g IV q6h (broader coverage for nosocomial/Gram-negative spectrum)
If MRSA suspected (post-influenzal, CXR with cavitation in appropriate clinical context):
- Add Vancomycin 15–20 mg/kg IV q12h (target trough 15–20 mg/L) OR Linezolid 600 mg IV/PO q12h
Harrison's 22E: Clindamycin 600 mg IV TID → 300 mg PO QID is the established regimen; metronidazole alone is not adequate (misses microaerophilic streptococci)
2. Infusion / Fluid Resuscitation (sepsis protocol)
- IV crystalloids (0.9% NaCl or Lactated Ringer's): 30 mL/kg bolus for hypotension, then maintenance
- Colloids (albumin 10% 200 mL) if persistent hypotension despite crystalloids
3. Antipyretics / Analgesics
- Paracetamol (acetaminophen) 500–1000 mg PO/IV q6h — fever and pain control
- NSAIDs (ibuprofen 400 mg TID with food) only if renal function preserved and no contraindications; avoid if hemoptysis significant
4. Mucolytics / Expectorants
- Ambroxol (Lazolvan) 30 mg PO TID or Acetylcysteine 600 mg PO once daily — facilitate drainage of purulent secretions
5. Bronchodilators (if bronchospasm component)
- Salbutamol (albuterol) 2.5 mg via nebulizer q8h — improve airway clearance
6. Oxygen Therapy
- Supplemental O₂ via nasal cannula 2–4 L/min or face mask 6–8 L/min targeting SpO₂ ≥92%
- Prepare for non-invasive ventilation (NIV/CPAP) if respiratory failure worsens
7. Gastroprotection
- Omeprazole 20 mg IV/PO once daily — prevent stress ulcer during IV antibiotics and critical illness
8. Anticoagulation (prophylactic)
- Enoxaparin 40 mg SC once daily — DVT prophylaxis (bedbound, septic patient)
9. Nutritional Support
- Consider nasogastric feeding if patient cannot maintain oral intake; consult dietitian
Surgical / Procedural Interventions (if indicated)
- Thoracentesis if significant pleural effusion (empyema criteria: pH <7.2, glucose <3.3 mmol/L, positive culture) → chest tube drainage
- Bronchoscopy — both diagnostic (culture) and therapeutic (secretion clearance)
- CT-guided percutaneous drainage if abscess >6–8 cm or fails to respond after 7–10 days of appropriate antibiotics
- Surgical resection (lobectomy) — reserved for failure of all above, massive hemoptysis, or abscess size precluding drainage
Monitoring
- Daily temperature, HR, BP, RR, SpO₂
- CBC + CRP every 48–72 hours
- Chest X-ray at days 3–5, then weekly
- CT chest at 4–6 weeks to confirm resolution
Sources: Harrison's Principles of Internal Medicine 22E (2025), Chapter 132 — Lung Abscess; Fishman's Pulmonary Diseases and Disorders, Chapter 127; Goldman-Cecil Medicine; Schwartz's Principles of Surgery 11E.
This is a shared conversation. Sign in to Orris to start your own chat.